Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangdi Li

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Clinical Microbiology Reviews|June 10, 2016
Approved Antiviral Drugs over the Past 50 YearsErik De Clercq, Guangdi Li
Antiviral Research|February 28, 2017
Current therapy for chronic hepatitis C: The role of direct-acting antiviralsGuangdi Li, Erik De Clercq
Medicinal Research Reviews|October 12, 2021
A medicinal chemist who reshaped the antiviral drug industry: John Charles Martin (1951-2021)Guangdi Li, Erik De Clercq
Microbiology and Molecular Biology Reviews : MMBR|July 1, 2016
HIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchGuangdi Li, Erik De Clercq
Travel Medicine and Infectious Disease|December 20, 2022
Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orfErik De Clercq, Yike Jiang, Guangdi Li
Biomedicines|April 30, 2021
Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global PerspectiveMiao Miao, Erik De Clercq, Guangdi Li
Acta Pharmaceutica Sinica. B|July 18, 2022
Approved HIV reverse transcriptase inhibitors in the past decadeGuangdi Li, Yali Wang, Erik De Clercq
Acta Pharmaceutica Sinica. B|September 1, 2023
Erratum: Author correction to 'Approved HIV reverse transcriptase inhibitors in the past decade' [Acta Pharmaceutica Sinica B 12 (2022) 1567-1590]Guangdi Li, Yali Wang, Erik De Clercq
Microorganisms|September 23, 2022
Towards Efficient and Accurate SARS-CoV-2 Genome Sequence Typing Based on Supervised Learning ApproachesMiao Miao, Erik De Clercq, Guangdi Li
Expert Opinion on Drug Metabolism & Toxicology|January 7, 2020
Clinical significance of chemokine receptor antagonistsMiao Miao, Erik De Clercq, Guangdi Li
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Clinical Microbiology Reviews|June 10, 2016
Approved Antiviral Drugs over the Past 50 YearsErik De Clercq, Guangdi Li
Antiviral Research|February 28, 2017
Current therapy for chronic hepatitis C: The role of direct-acting antiviralsGuangdi Li, Erik De Clercq
Medicinal Research Reviews|October 12, 2021
A medicinal chemist who reshaped the antiviral drug industry: John Charles Martin (1951-2021)Guangdi Li, Erik De Clercq
Microbiology and Molecular Biology Reviews : MMBR|July 1, 2016
HIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchGuangdi Li, Erik De Clercq
Travel Medicine and Infectious Disease|December 20, 2022
Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orfErik De Clercq, Yike Jiang, Guangdi Li
Biomedicines|April 30, 2021
Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global PerspectiveMiao Miao, Erik De Clercq, Guangdi Li
Acta Pharmaceutica Sinica. B|July 18, 2022
Approved HIV reverse transcriptase inhibitors in the past decadeGuangdi Li, Yali Wang, Erik De Clercq
Acta Pharmaceutica Sinica. B|September 1, 2023
Erratum: Author correction to 'Approved HIV reverse transcriptase inhibitors in the past decade' [Acta Pharmaceutica Sinica B 12 (2022) 1567-1590]Guangdi Li, Yali Wang, Erik De Clercq
Microorganisms|September 23, 2022
Towards Efficient and Accurate SARS-CoV-2 Genome Sequence Typing Based on Supervised Learning ApproachesMiao Miao, Erik De Clercq, Guangdi Li
Expert Opinion on Drug Metabolism & Toxicology|January 7, 2020
Clinical significance of chemokine receptor antagonistsMiao Miao, Erik De Clercq, Guangdi Li
Pageof 10